Cite
HARVARD Citation
Kizy, S. et al. (n.d.). Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy. HPB. pp. S571-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kizy, S. et al. (n.d.). Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy. HPB. pp. S571-. [Online].